(Q51355720)
Statements
A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. (English)
1 reference
K E Truitt
1 reference
H S Chou
1 reference
J B Moberly
1 reference
D Merante
1 reference
Y Choi
1 reference
Y Mun
1 reference
A Pfützner
1 reference
4 July 2012
1 reference
14
1 reference
11
1 reference
1000-1009
1 reference
1 reference